News
MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the Pharmaceutical Benefits Advisory Committee (PBAC ...
Luke FaulksLocal Journalism Initiative ReporterPique NewsmagazineA Pemberton resident and her family are appealing to the ...
12h
TipRanks on MSNBristol-Myers Squibb’s New Lung Cancer Study: Potential Market Impact
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
13h
TipRanks on MSNIncyte’s Phase 3 Study on Pembrolizumab and Epacadostat: Key Insights for Investors
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 3 clinical ...
"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...
This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.
UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
THOUSANDS of Brits with bladder cancer could survive for twice as long after a new treatment was given the green light to be ...
Some 1200 patients a year in England are set to benefit from a “breakthrough” life extending treatment for bladder cancer after the National Institute for Health and Care Excellence (NICE) approved it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results